Browsing: Jenkins

BioCryst Pharmaceuticals has appointed David W. Jenkins, Ph.D., as its first chief scientific officer, a newly created executive role designed to strengthen the company’s research strategy as it expands its rare disease pipeline through external innovation and partnerships. The appointment is effective immediately, with Jenkins reporting to Chief Research and Development Officer Dr. Sandeep Menon…